Brief: Moberg Pharma Completes Divestment The OTC-Business For $155 Mln
March 29 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* MOBERG PHARMA COMPLETES THE DIVESTMENT OF THE OTC-BUSINESS
FOR
USD 155 MILLION
Source text for Eikon: ID:nWkr9cNTfR
Further company coverage: MBPH.ST
((Reuters.Briefs@thomsonreuters.com;))